Back to
DANSKE BANK A/S
CPHI5 quarters
Position history for
DANSKE BANK A/S's holdings in CHINA PHARMA HLDGS INC
Yes. Danske Bank holds 1 shares of CPHI (China Pharma), worth $1, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Danske Bank has held CPHI since Q2 2025, across 5 quarterly 13F filings.
Current Value
$1
Current Shares
1
Total Value Change
-$1
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CPHI: UBS Group AG, CITADEL ADVISORS LLC